We provided evidence that competitive inhibition of poly(ADP-ribose) polymerases in mammalian cells treated with 3-aminobenzamide causes DNA hypermethylation in the genome and anomalous hypermethylation of CpG islands. The molecular mechanism(s) connecting poly(ADP-ribosyl)ation with DNA methylation is still unknown. Here we show that DNMT1 is able to bind long and branched ADP-ribose polymers in a noncovalent way. Binding of poly ADP-ribose on DNMT1 inhibits DNA methyltransferase activity. Co-immunoprecipitation reactions indicate that PARP1 and DNMT1 are associated in vivo and that in this complex PARP1 is present in its ADP-ribosylated isoform. We suggest that this complex is catalytically inefficient in DNA methylation.
Introduction
DNA methylation, the major modification of eukaryotic genomes, is essential for mammalian development and is correlated with imprinting, X-chromosome inactivation, stable transcriptional silencing and tumorigenesis (Bestor, 2000; Costello and Plass, 2001; Jones and Takai, 2001; Bird, 2002; Jones and Baylin, 2002) .
This epigenetic modification in mammalians occurs predominantly at position 5 of cytosines when followed by guanosine (CpG), and is catalysed by three DNA methyltransferases, DNMT1, DNMT3a and DNMT3b, which have different capacities for maintenance and de novo methylation (Leonhardt et al., 1992; Okano et al., 1999; Robertson et al., 1999) . The main mammalian DNA methyltransferase DNMT1 is localized in replication foci and is primarily responsible for copying methylation patterns after replication (Bestor and Verdine, 1994; Pradhan et al., 1999) , whereas DNMT3a and DNMT3b exhibit de novo activity, establishing new methylation patterns during embryogenesis (Okano et al., 1999) . A possible interplay between DNMT1 and DNMT3b has been described (Datta et al., 2003) . Also a DNA demethylase activity, through a mechanism still to be defined, is involved in defining the methylation pattern (Bird, 2003) . As for the distribution of mCpGs, they are distributed in a nonrandom fashion in genomic DNA. Throughout the bulk DNA, the few CpG dinucleotides present are mostly methylated, while the unmethylated ones are mainly located within particular DNA regions termed CpG islands (Bird, 1986; Takai and Jones, 2002) . The unmethylated state of these DNA regions (1-2% of DNA) is unexpected since their sequence is 6.5 times richer in dinucleotide CpGwhich is the best substrate for cytosine methylationthan the remaining 98% of genome (Bird et al., 1985; Bird, 1992) .
Our previous data showed that competitive inhibition of poly(ADP) ribose polymerases, through treatment of cells with 3-aminobenzamide, leads to in vivo DNA hypermethylation, causing also an anomalous introduction of methyl groups into CpG islands (Zardo et al., 1997; de Capoa et al., 1999) . The aim of this paper is to investigate how poly(ADP-ribosyl)ation controls and/or protects the DNA methylation pattern.
Poly(ADP-ribose) polymerases make up a family of enzymes which, using NAD as substrate, build ADPribose polymers by adding ADP-ribose units one at a time until polymers of 2-200 units are formed (D'Amours et al., 1999) . Poly(ADP-ribose) polymerase1 (PARP1), the main member of this family, hosts polymers in its central domain where 28 automodification sites are present; these sites have the glutamic acid necessary for the first link (Rolli et al., 2000) . Apart from modifying covalently acceptor proteins, long and branched polymers are able to bind noncovalently to proteins with important functional roles (Althaus et al., 1995; Malanga et al., 1998; Pleschke et al., 2000) ; the polymers can be free or still bound to PARP1. Considering the chemical structure of polymers, they resemble nucleic acids with a great number of negative charges that modify the acceptor proteins. This very strong interaction (Panzeter et al., 1992) introduces, therefore, a structural and functional modification of these proteins, supporting a role for ADP-ribose polymers as 'molecular adaptors'. The interaction between the polymers and the modified proteins is nonionic in nature since it does not depend on the basic charge of proteins; rather, it depends on the presence of a particular amino-acid motif, which represents the consensus domain for the noncovalent link with ADPribose polymers (Schmitz et al., 1998; Pleschke et al., 2000) .
Through a computer-assisted sequence analysis, we found on DNMT1 two amino-acid motifs, which resemble that consensus sequence. Here we show that DNMT1 is part of a protein family able to bind, in a noncovalent way, long and branched ADP-ribose polymers and that ADP-ribose polymers, either free or PARP1 bound, are able to inhibit DNA methyltransferase activity. These in vitro results, taken together with coimmunoprecipitation data, showing that poly(ADPribosyl)ated PARP1 and DNMT1 form complexes in vivo, allow us to suggest that poly(ADP-ribosyl)ated PARP1, by forming a PARP1-DNMT1 complex, which is catalytically incompetent in DNA methylation, is involved in protecting the DNA methylation pattern.
Results

Poly(ADP-ribose) binds noncovalently to DNMT1
Recent studies show the presence of specific poly(ADPribose)-binding motifs in a group of proteins (Schmitz et al., 1998; Pleschke et al., 2000) . The typical motif contains two conserved regions: (i) a cluster rich in positive residues and (ii) the consensus patternhxbxhhbbhhb-, where h indicates residues with hydrophobic side chains, b stands for a preference for basic amino-acid residues and x is any amino-acid residue. Computer-assisted sequence analysis revealed that two sequences that resemble such a motif are present in the N-terminal domain of DNMT1 (Figure 1a ). This finding has prompted us to investigate the ability of DNMT1 to bind ADP-ribose polymers using a nitrocellulose polymer blot assay. H1 histone and DNaseI in equal amounts of weight with respect to DNMT1 (1 mg) were dotted onto the same nitrocellulose membrane. H1 histone, having a high affinity for poly(ADP-ribose), was used as positive control, while DNaseI represented the negative one. Figure 1b shows a significant dot blot signal for polymer binding to human recombinant DNMT1. This binding signal was lower than that of H1 histone and no binding was shown for DNaseI. Addition of excess ssDNA or dsDNA (25-fold weight excess over poly(ADP-ribose)) showed that, although ssDNA competes better than dsDNA with ADP-ribose polymers for binding DNMT1, it was not able to remove completely polymers associated to DNMT1. Under the same conditions, the amount of ADP-ribose polymers bound to H1 histone was not influenced by the presence of either competitor DNAs.
By spotting equal molar amounts of H1 histone and DNMT1 on the membrane and comparing their ability to bind ADP-ribose polymers, we observed that the signal obtained by dot-blotting 10 pmol of H1 corresponded to that of 2 pmol of DNMT1 (Figure 1c ). We can recognize an accumulation of basic residues at the N-terminal side of the motif (K/R), followed by the consensus pattern with hydrophobic amino acids (h: ACGVILMFYW), spaced by basic amino acids (b: KRH). Conserved hydrophobic residues are indicated in bold against a light grey area, conserved basic residues are indicated in bold against a dark grey area. Neighbouring basic amino acids are indicated in bold. In a polymer blot assay, 1 mg of purified proteins (b) or 2, 4 or 10 pmols of purified H1 histone and human DNMT1 (c) were dotted on nitrocellulose membrane. In (b), blots were incubated with radiolabelled free ADP-ribose polymers in the absence (À) or presence of either ssDNA or dsDNA. Histone H1 was used as positive control, while DNaseI as the negative one. In (c) blots were incubated with radiolabelled free ADP-ribose polymers. Protein-bound polymers were visualized by autoradiography DNA methyltransferase activity of nuclear extracts and in vitro effect of ADP-ribose polymers, either free or PARP1-bound, on human DNMT1 activity
In Figure 2a , we compared the ability of nuclear extracts from control and DPQ-treated cells to transfer labelled methyl groups from S-adenosyl-L-[methyl-
3 H]methionine ( 3 H-SAM) to an exogenous DNA. DPQ (3-4-dihydro-5-[4(1-piperidinyl)butoxy]-1(2H)-isoquinoline) is a very potent PARP inhibitor. The incorporation of methyl groups on DNA was 2.5 times higher with nuclear extracts from DPQ-treated cells than with nuclear extract from control cells, whose incorporation was 0.1470.03 pmol of 3 H-SAM and was taken as 100%. This result indicates a functional relationship between DNMT1 and PARP1, and is consistent with previous observations that cells treated with PARP inhibitors resulted in DNA hypermethylation (Zardo et al., 1997 Zardo and Caiafa, 1998; de Capoa et al., 1999) .
To determine whether the lower endogenous DNA methyltransferase activity evidenced in nuclear extracts from control cells was correlated to the presence of polymers, we performed methylation assays with purified human recombinant DNMT1 in the presence of ADPribose polymers, either free or PARP1-bound. The effect of free polymers on human recombinant DNMT1 activity was tested using a polymer : DNA ratio 0.3 (w/ w) and detecting the residual DNA methyl-accepting ability ( Figure 2b ). Considering as 100% the DNMT1 activity in the absence of polymers which corresponded to the incorporation of 1.7470.05 pmol 3 H-SAM, we obtained a 91.573% inhibition in the presence of polymers. Then we examined the effect of human recombinant PARP1 and autopoly(ADP-ribosyl)ated PARP1 on DNMT1 activity (Figure 2c ). In the presence of NAD, PARP1 uses the ADP-ribosyl moiety of NAD to automodify itself in successive transfer cycles forming long and branched chains of poly(ADP-ribose). Addition of human recombinant PARP1 to a methylation assay in the absence of NAD was not inhibitory on DNMT1 activity (data not shown); thus, the activity of DNMT1 assayed in the presence of PARP1 but in the absence of NAD (in standard DNMT1 buffer with added MgCl 2 ) was taken as 100% (control). Incorporation under these conditions at 45 and at 60 min corresponded to 0.4170.04 and 0.6170.07 pmol of 3 H-SAM, respectively. After addition of NAD and incubation for 45 and 60 min, we observed a significant decrease in the methyl transfer reaction, with residual DNMT1 activity corresponding to 57715 and 4172.5%, respectively, of the control activity. We infer that, in the presence of NAD, PARP1 is efficiently automodified with 60 min of incubation, leading to an increase in the polymer size and complexity when compared to the shorter incubation period. The NAD-mediated automodification of PARP1 inhibits DNMT1 activity.
To more directly assess whether the inhibition of DNMT1 activity was linked to increased automodification of PARP1, we tested whether the addition of DPQ, by inhibiting the synthesis of polymers on PARP1, could restore DNMT1 activity. In a sample containing all the reagents for PARP1 automodification and DNMT1 activity plus DPQ, we observed that the presence of DPQ annulled the inhibitory effect on DNA methyltransferase activity. Moreover, when ADP-ribose polymers were added to this sample at a polymer/DNA ratio of 0.3 (w/w), we obtained the same percentage of inhibition of DNA methyltransferase activity observed when DNMT1 activity was assayed in the presence of free polymers (Figure 2c ). These results confirm that ADP-ribose polymers bound to PARP1 can cause repression of the methyltransferase activity.
Coimmunoprecipitation
Coimmunoprecipitation experiments were performed to verify the existence of an in vivo association between DNMT1 and PARP1. Experiments were performed was tested in a standard buffer containing 10 mM MgCl 2 and M. luteus dsDNA. The assay was carried out for 45 or 60 min at 371C in the absence of NAD & (control assay considered as 100%) or in the presence of NAD . Additional experiments confirmed that inhibition of DNMT1 activity was actually due to automodification of PARP1. In a tube containing all the reagents needed to induce PARP1 automodification, the synthesis of polymers was inhibited by adding DPQ , and in a parallel tube the addition of DPQ was supplemented of ADP-ribose polymers at a polymer : DNA ratio of 0.3 . Histograms, in which error bars have been included, represent the average of three separate experiments DNMT1 as a target for ADP-ribose polymers A Reale et al both on nuclear extracts from L929 mouse fibroblasts and on the protein-protein adducts containing nonchromatin-bound proteins and devoid of DNA, isolated by isopicnic centrifugation on cesium chloride gradients of nuclear extracts from fixed HeLa cells. Preclarified nuclear extracts, or the preclarified protein-protein adduct fractions, were incubated with anti-DNMT1 antibodies, specific for mouse or human DNMT1, respectively. The presence of PARP1 and ADP-ribose polymers in the immunoprecipitate was analysed by Western blotting using specific antibodies (Figure 3 ). Several repetitions of the coimmunoprecipitation experiments provided the same results, which indicate that PARP1 and DNMT1 are associated in vivo and that PARP1, which co-precipitated with DNMT1, is present in its automodified isoform (Figure 3 ).
Discussion
Our previous results showed that inhibition of poly (ADP-ribosyl)ation allowed the introduction of new anomalous methyl groups onto genomic DNA and onto CpG island regions, suggesting that in the absence of ADP-ribose polymers some regions were no longer protected from methylation (Zardo et al., 1997; de Capoa et al., 1999) .
The important role played by DNA methylation in the modulation of gene expression is mainly correlated to the methylation pattern of CpG islands in the promoter gene regions: the housekeeping genes are expressed only when the CpG islands are in unmethylated state (Bird et al., 1985; Bird, 1992) . The mechanism(s) by which these DNA regions are protected from methylation both during replication and in chromatin is still unknown, although different suggestions have been put forward (Brandeis et al., 1994; Bird, 2002; Clark and Melki, 2002; Feltus et al., 2003) .
The results presented in this paper demonstrate that DNMT1 can be considered a member of the protein family able to bind long and branched ADP-ribose polymers in a noncovalent way. Although our in vitro assays do not allow us to determine the level of affinity of poly(ADP-ribose) for DNMT1, they indicate that the affinity should be sufficiently high to allow the formation of a complex in vivo, which indeed turned out to be the case (see below).
That poly(ADP-ribosyl)ation might play a role in the regulation of DNMT1 activity has been shown through experiments in which the endogenous DNA methyltransferase activity of nuclear extracts from control and DPQ-treated cells has been evaluated. Inhibition of PARP1 activity by DPQ leads to a strong increase of DNMT1 enzymatic activity. Parallel experiments have shown that ADP-ribose polymers either free or PARP1 bound are inhibitory on in vitro human recombinant DNMT1 activity.
Immunoprecipitation reactions under physiologic and high stringency conditions show that DNMT1 and PARP1 are associated in vivo. Most experiments to date use formaldehyde crosslinking and chromatin immunoprecipitation to characterize the DNA sequences associated with DNA-binding proteins. We combined the crosslinking procedure with isolation of protein-protein adducts from gradients; the rationale for performing the experiments in this way was to avoid potential artefacts due to the possibility that residual DNA present in a nuclear extract could favour the co-precipitation of two DNA-binding proteins, such as DNMT1 and PARP1. Formaldehyde crosslinking has an additional important advantage: crosslinking allowed us to use very stringent conditions of immunoprecipitation (high detergents) without the risk of losing the association between the two proteins. It is therefore one of the most rigorous ways to demonstrate the specificity of the antibody reactions.
Although the presence of ADP-ribose polymers on the co-precipitated PARP1 and in vitro data suggest that polymers might play a direct role in DNMT1-PARP1 interaction, our experiments cannot exclude a possible interaction of polymers with another protein playing a regulatory role in the complex.
Taking into consideration all available data, we suggest the model for a possible molecular mechanism control in the methylation pattern on genomic DNA. During normal cell growth DNMT1, having a higher affinity for ADP-ribose polymers than for DNA, is associated with modified PARP1, allowing the formation of the PARP1-ADP-ribose polymers-DNMT1 complex. This interaction precludes DNMT1 binding to DNA, thus preventing DNA methylation.
We speculate that PARP1 protects the unmethylated state of CpG islands. That PARP1 and ADP-ribose polymers can exert their effect on CpG islands is supported by the following observations: (i) PARP1 Figure 3 In vivo association of DNMT1 with modified PARP1. Immunoprecipitation reactions were carried out on nuclear extracts from L929 mouse fibroblasts under native conditions (a) and on the protein-protein adducts containing nonchromatin-bound proteins purified on cesium chloride density gradients from nuclear extract of fixed HeLa cells (b). (a) Input corresponds to 20% of the nuclear extract used for immunoprecipitation. Antibodies against mouse DNMT1 were used to immunoprecipitate 0.2 mg of nuclear lysate (IP anti-mDNMT1). Control goat IgG does not bind to DNMT1 (no Ab). (b) Input corresponds to 10% of the protein-protein adduct which was subjected to immunoprecipitation. Antibodies against human DNMT1 were used to immunoprecipitate 100 mg of this sample (IP anti-hDNMT1). Control reactions were carried out in the absence of antibody (no Ab). In both experiments, specific anti-DNMT1 and anti-PARP1 antibodies were used to detect the presence of the two enzymes in the coimmunoprecipitate. To evaluate the amount of polymers associated with PARP1, antipoly(ADP-ribose) antibodies were used on the same membrane on which PARP1 had been detected, following stripping of the anti-PARP1 antibody
DNMT1 as a target for ADP-ribose polymers
A Reale et al has been found to be associated with regions actively transcribed by RNA polymerase II (Fakan et al., 1988) ; (ii) PARP1 activity is observed in areas of highly transcriptionally active decondensed chromatin (chromosomal puffs in Drosophila) (Tulin and Spradling, 2003) and (iii) CpG islands are coincident with the promoters of approximately 60% of human RNA polymerase II-transcribed genes (Antequera and Bird, 1993) . In normal cells, the unmodified PARP1 molecules considerably outnumber the poly(ADP-ribosyl)ated ones (D'Amours et al., 1999; Kun et al., 2002) . This situation can be explained considering that PARP1 is involved both in situations of cellular emergency (D'Amours et al., 1999; Ame´et al., 2000) and in physiologic regulation of biological events (Kraus and Lis, 2003) . PARP1 activity is therefore highly regulated: although background PARP activity is always present under normal physiological conditions where genome integrity is maintained (Griesenbeck et al., 1999) , the enzyme is dramatically activated in response to extensive DNA damage (Rolli et al., 2000) . Obviously, suggesting a role for PARP1 in controlling DNMT1 activity in chromatin, we are looking at those few active molecules of PARP1 which might be located on CpG islands. Determining which factor recruits and stimulates PARP1 enzymatic activity on CpG islands is an unresolved issue. In conclusion, while several studies have indicated a direct involvement of PARP1 in transcription either with positive or negative effects (Meisterernst et al., 1997; Butler and Ordhal, 1999; D'Amours et al., 1999; Hassa and Hottinger, 2002; Ku et al., 2003) , our model, suggesting a mechanism whereby ADP-ribose polymers exclude methylation from CpG islands, assigns to PARP1 an indirect impact on gene expression.
Since hypermethylation of CpG islands located in the promoter regions of tumor suppressor genes is an important mechanism for gene inactivation described in many tumor types, PARP1 could epigenetically control DNMT1 activity, ensuring the maintenance of unaltered DNA methylation patterns. The future challenge would be to demonstrate that a decrease in PARP1 level or PARP1 activity could be linked to CpG hypermethylation in human cancer.
Materials and methods
Cell cultures
L929 mouse fibroblasts were grown in Glasgow Minimal Essential Medium (GMEM) supplemented with 10% newborn calf serum until they reached 80% confluence. An aliquot of exponentially growing cells were incubated for 24 h with DPQ (Alexis Biochemicals), to a final concentration of 10 mM. Human HeLa cells were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum.
Purification of ADP-ribose polymers
Permeabilized L929 mouse fibroblasts were treated with 15 mM N-methyl-N 0 -nitro-N-nitrosoguanidine (MNNG) for 10 min to activate endogenous PARPs and incubated with 50 mM NAD or 50 mM [ 32 P]NAD (Perkin-Elmer Life Sciences, 30 Ci/mmol) in 50 mM Tris-HCl, pH 7.4, 45 mM KCl, 0.1 mM PMSF and 5 mM DTT at room temperature for 15 min. The reaction was blocked by addition of trichloroacetic acid to a final concentration of 20% (w/v). ADP-ribose polymers were purified according to the methods of Aboul-Ela (Aboul-Ela et al., 1988) and of Malanga and Althaus (1994) .
Poly (ADP-ribose) blot analyses
Purified proteins in equal weight amounts (1 mg) or in equal molar amounts (2, 4, 10 pmol) were dotted on nitrocellulose membrane (Hybondt ECLt Amersham Pharmacia Biotech). The blots were treated as described previously (Panzeter et al., 1993) . Briefly, blots were incubated in 5 ml of Tris-buffered saline (TBS, 10 mM Tris, 0.15 M NaCl, pH 7.4) plus 0.05% (v/ v) Tween 20 (TBST) containing [ 32 P]ADP-ribose polymers (0.4-0.7 mg) in the absence (control) or presence of either ssDNA or dsDNA (1200 bp long from human placenta), at a poly(ADP-ribose) : DNA ratio of 1 : 25 (w/w). After incubation for 1 h at room temperature, the membranes were extensively washed with TBST containing 0.5 M NaCl, dried and subjected to autoradiography.
Preparation of nuclear extract from L929 mouse fibroblasts and HeLa cells
HeLa cells were fixed for 15 min by adding 0.1 v of formaldehyde buffer (11% formaldehyde, 100 mM NaCl, 1 mM EDTA, 50 mM Hepes-KOH, pH 8.0). To stop the crosslinking reaction, glycine pH 2.5 was added to 0.125 mM. Fixed HeLa cells and L929 mouse fibroblasts were rinsed twice in PBS, harvested, centrifuged at 1000 g for 10 min. Cell pellets were lysed by incubation at 41C for 1 h in lysis buffer (10 mM Tris-HCl, pH 7.8, 4 mM MgCl 2 , 1 mM EDTA, 0.5 mM DTT, 1% Triton X-100, 0.25 M sucrose). Nuclei were resuspended in 20 mM Tris-HCl, pH 7.8, 0.3 M NaCl, 3 mM DTT and 3% glycerol. Samples were sonicated for 3 Â 10 s, protease inhibitors (1 mg/ml leupeptin, 2 mg/ml pepstatin A, 3 mg/ml aprotinin, E64 5 mg/ml) were added, and kept on ice for 60 min, mixing every 10 min. Debris was removed by centrifugation. The supernatants of L929 mouse fibroblasts appropriately diluted to reduce NaCl concentration were used for DNMT1 activity assays and immunoprecipitation under native conditions. HeLa cells supernatant was fractioned by cesium chloride isopycnic centrifugation.
Endogenous DNA methyltransferase activity
Nuclear extracts from mouse fibroblasts treated for 24 h with 10 mM DPQ and untreated (control) were used for evaluating endogenous DNA methyltransferase activity. In a final volume of 100 ml, aliquots of nuclear extracts, corresponding to 20 mg of proteins, were incubated with 2 mg of Micrococcus luteus DNA using as methyl donor 5 mM S-adenosyl-L-methionine (SAM) plus 5 mCi 3 H-SAM (specific activity 55 Ci/mmol, NEN Life Science) for 2 h at 371C. The samples were treated as described previously (Zardo et al., 1997) .
DNA methyltransferase assay with human recombinant DNMT1
Human recombinant DNMT1 was expressed in a Baculovirus expression vector and purified according to Pradhan et al. (1999) Its activity was assayed at 371C for 1 h, by using 0.5 mg of enzyme, 5 mM SAM plus 3 mCi luteus DNA in 25 ml of assay buffer (50 mM Tris-HCl, pH 7.8, 1 mM Na 2 EDTA, 1 mM DTT, 5% glycerol).
The effect of the ADP-ribose polymers on DNA methylation was tested at a polymer : DNA ratio of 0.3 (w/w). The effect of human recombinant PARP1 (Alexis) on DNMT1 activity was tested in the presence or absence of 0.25 mM NAD. Fixed concentrations of PARP1 and DNMT1 (25 nM) were incubated for 45 or 60 min with 1 mg of M. luteus DNA (used both as methyl group acceptor and PARP1 activator) plus SAM in 25 ml of the standard DNMT1 enzymatic buffer containing 10 mM MgCl 2 and, when indicated, NAD. To some of the samples either 20 mM of DPQ or 20 mM of DPQ plus ADP-ribose polymers at a polymer : DNA ratio of 0.3 (w/w) were added.
After the indicated times of incubation at 371C, the reactions were stopped and treated as described previously (Zardo et al., 1997) . The radioactivity incorporated on DNA was measured. DNMT1 assays were carried out in triplicate and results reported are the average of three separate experiments, taking as 100% the DNMT1 activity in the presence of unmodified PARP1.
Cesium chloride gradient centrifugation of nuclear extract from HeLa cells fixed with formaldehyde and identifications of fractions containing nonchromatin-bound DNMT1 and PARP1
The HeLa supernatant was adjusted to 0.5% sarkosyl (sodium lauryl sarcosine), 150 mM NaCl in 8 ml of TE, then adjusted to 1.42 g/cm 3 CsCl (567.8 mg/ml), brought to 10.5 ml with the same TE-sarkosyl buffer and centrifuged in a Beckman SW 40 rotor at 35 000 r.p.m. for 48-72 h at 41C. Fractions of 0.6 ml were collected, 50 ml of each fraction was analysed for DNMT1, PARP1 and H1 histone content by dot-blot analysis. The determination of H1 on dot-blot was performed to identify and exclude fractions containing DNA, since H1 histone is the most abundant protein bound to DNA. A refractometer was used to check the exact density of each fraction in order to collect fractions with a density corresponding to that of a protein-protein adduct. Three fractions, containing nonchromatin-bound proteins devoid of DNA, were pooled and dialysed overnight at 41C against 1 mM Na 2 EDTA, 10 mM Tris-HCl, pH 8.0.
Immunoprecipitation under physiologic and high-stringency conditions
Unfixed nuclear extracts from L929 mouse fibroblasts were diluted to bring the final solution to 20 mM Tris-HCl, pH 7.8, 0.15 M NaCl, 3 mM DTT and 3% glycerol (IP buffer). Aliquots normalized for total protein content (0.2 mg) were precleared by adding 30 ml of protein G-Sepharose (GammaBindtG Sepharose; Amersham Pharmacia Biotech) prewashed in IP buffer. After incubation at 41C for 45 min, the samples were centrifuged. Goat polyclonal antibodies against mouse DNMT1 (C-17, Santa Cruz Biotech. Inc.) diluted 1 : 50 were added to the supernatants and incubated for 1 h at 41C. Quantitative precipitation of the immunocomplexes was achieved by donkey anti-goat immunoglobulins (Santa Cruz Biotech, Inc.) added to a final dilution of 1 : 500; incubation was for 30 min. Antibody-bound material was pelleted with 100 ml of protein G-Sepharose. After 1 h of incubation at 41C, the resin was washed three times with 1 ml of IP buffer and proteins were eluted from it by boiling in Laemmli buffer (Laemmli, 1970) .
The sample from fixed HeLa nuclear extracts containing nonchromatin-bound DNMT1 and PARP1 was adjusted to 150 mM NaCl, 1% NP-40, 50 mM Tris-HCl, pH 8.0, plus protease inhibitors (NP-buffer). It was precleared for 1 h at 41C on protein A-agarose (Upstate) and incubated for 2 h with anti-human DNMT1 rabbit polyclonal antibodies (New England Biolabs). A control immunoprecipitation with no antibody was carried out. Antibody-bound material was pelleted with 100 ml of protein A-agarose. After 1 h of incubation at 41C, the resin was washed five times with 1 ml of NP buffer. Reversal of crosslinks and protein elution from resin were achieved by heating the resin in Laemmli buffer for 4-5 h at 651C.
Western blots were performed according to standard procedures. Antibodies against DNMT1 or PARP1 (C2-10, Alexis) were used to detect the relative proteins. Reprobing of the blot previously reacted with anti-PARP1 antibodies with monoclonal antibodies to poly(ADP-ribose) (Alexis) revealed the endogenous poly(ADP-ribosyl)ation level of PARP1. After incubation with horseradish peroxidase-conjugate secondary antibodies, blots were developed by chemiluminescence reaction (ECL-Plus, Amersham Pharmacia Biotech).
